| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
D-amino acid oxidase | 0.636 | 0.615 | 6.2E-22 |
|
disease | 0.400 | None | 0.920 | 49 | 7 | 2002 | 2019 | ||||||||
|
regulator of G protein signaling 4 | 0.621 | 0.577 | 5.1E-08 |
|
disease | 0.100 | None | 0.894 | 46 | 1 | 2001 | 2018 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.964 | 46 | 7 | 1993 | 2020 | ||||||||
|
D-amino acid oxidase activator | 0.678 | 0.346 | 1.4E-04 |
|
disease | 0.500 | None | 0.965 | 45 | 8 | 2002 | 2018 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.400 | None | 0.854 | 44 | 11 | 1998 | 2020 | ||||||||
|
glutamate metabotropic receptor 3 | 0.606 | 0.538 | 0.78 |
|
disease | 0.500 | None | 0.885 | 43 | 9 | 2002 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.400 | None | 0.667 | 42 | 3 | 2007 | 2020 | ||||||||
|
cholinergic receptor nicotinic alpha 7 subunit | 0.532 | 0.654 | 4.2E-04 |
|
disease | 0.700 | None | 0.750 | 41 | 2 | 1998 | 2019 | ||||||||
|
neurexin 1 | 0.581 | 0.692 | 1.00 |
|
disease | 0.700 | None | 0.932 | 41 | 8 | 2008 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.600 | None | 0.951 | 40 | 6 | 2000 | 2019 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.500 | None | 0.750 | 40 | 5 | 2000 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.950 | 39 | 1 | 1994 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.400 | None | 0.400 | 38 | 1 | 1994 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 0.900 | 38 | 5 | 1997 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.600 | None | 0.780 | 37 | 0 | 1995 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.700 | None | 0.972 | 34 | 17 | 2000 | 2020 | ||||||||
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
disease | 0.400 | None | 1.000 | 34 | 1 | 2002 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.400 | None | 1.000 | 32 | 4 | 1991 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.400 | None | 1.000 | 32 | 1 | 1995 | 2019 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.100 | None | 0.828 | 29 | 7 | 1980 | 2018 | ||||||||
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.100 | None | 0.897 | 28 | 1 | 1993 | 2017 | ||||||||
|
dopamine receptor D1 | 0.529 | 0.808 | 0.96 |
|
disease | 0.400 | None | 0.964 | 27 | 5 | 1995 | 2017 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 1 | 0.561 | 0.692 | 0.98 |
|
disease | 0.300 | None | 0.867 | 27 | 1 | 1994 | 2019 | ||||||||
|
glutamate metabotropic receptor 2 | 0.582 | 0.577 | 0.12 |
|
disease | 0.400 | None | 0.893 | 27 | 0 | 1995 | 2019 | ||||||||
|
monoamine oxidase A | 0.465 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 26 | 2 | 1996 | 2019 |